VELMENI Gets FDA 510(k) Clearance for 3D Dental Imaging Software
Jul 27, 2026
Healthcare
Cortechs.ai Gets FDA Clearance for NeuroQuant PET
August 18, 2026
Cortechs.ai said NeuroQuant PET received FDA 510(k) clearance for PET. The software provides automated PET quantification and structured reporting for cognitive impairment and other neurological conditions.
Cortechs.ai announced in a press release that NeuroQuant PET received U.S. Food and Drug Administration (FDA) 510(k) clearance for PET. The software aids physicians in evaluating patient pathologies and interpreting PET studies for cognitive impairment and other neurological conditions.
NeuroQuant PET provides automated quantification, regional analysis, and structured reporting for clinical workflows. It supports amyloid PET tracers including flutemetamol, florbetaben, and florbetapir, and generates standardized uptake value ratios and Centiloid measurements.
The platform supports PET CT, PET MR, and PET only workflows. It segments regions of interest and creates outputs prepared for PACS integration.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
08/18
Fractal Analytics Wins $17 Million AI Data Deal With U.S. Healthcare Enterprise
08/18
Silex Technology Launches EP-200N Edge AI Module for Industrial and Medical Devices
08/17
PhaseV Survey Says 88 Percent of Sponsors Face Trial Reporting Delays
08/17
Aizen Therapeutics Signs Oral Peptide Collaboration
08/17
Cognizant to Implement Benchling AI Platform for Kyowa Kirin Research Sites
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more